Solstice Oncology

Solstice Oncology is a clinical-stage immuno-oncology company developing a therapeutic that meets cancer at its most vulnerable moment, before surgery, to drive deep pathological response and return patients to lasting health. Their lead program is targeting colon cancer.


Website

www.solsticeoncology.com

Partner

Julie Grant

Investment

Series A